Gervais Rioux

PapMV nanoparticles improve mucosal immune responses to the trivalent inactivated flu vaccine

P. Savard, D. Leclerc, Marilène Bolduc, 2014, Journal of Nanobiotechnology.

Induction of innate immunity in lungs with virus-like nanoparticles leads to protection against influenza and Streptococcus pneumoniae challenge.

D. Leclerc, Gervais Rioux, C. Mathieu, 2013, Nanomedicine : nanotechnology, biology, and medicine.

Mapping the surface‐exposed regions of papaya mosaic virus nanoparticles

D. Leclerc, N. Majeau, Gervais Rioux, 2012, The FEBS journal.

Influence of PapMV nanoparticles on the kinetics of the antibody response to flu vaccine

P. Savard, D. Leclerc, Marilène Bolduc, 2016, Journal of Nanobiotechnology.

Engineering of Papaya Mosaic Virus (PapMV) Nanoparticles through Fusion of the HA11 Peptide to Several Putative Surface-Exposed Sites

D. Leclerc, N. Majeau, Gervais Rioux, 2012, PloS one.

A versatile papaya mosaic virus (PapMV) vaccine platform based on sortase-mediated antigen coupling

P. Savard, D. Leclerc, Marilène Bolduc, 2017, Journal of Nanobiotechnology.

Engineering of the PapMV vaccine platform with a shortened M2e peptide leads to an effective one dose influenza vaccine.

P. Savard, D. Leclerc, Marilène Bolduc, 2015, Vaccine.